Aliskiren or Amlodipine in Hypertensive Hemodialysed Patients
Status:
Unknown status
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
Hypertensive haemodialysis patients are at high risk for cardiovascular events. This study
was undertaken to ascertain whether aliskiren, a direct renin inhibitor, compared with
amlodipine, a calcium channel blocker, reduces mortality and cardiovascular events in these
high-risk patients.
Phase:
Phase 4
Details
Lead Sponsor:
Second University of Naples University of Campania "Luigi Vanvitelli"